Paralysis: Clinical Trials

9 trials for Paralysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Paralysis: new trials by email Literature Review of Paralysis trials Research Report on Paralysis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Albuterol to Improve Respiratory Strength in SCI
Oral Albuterol Extended Release, Placebo - Spinal Cord Injury, Respiratory Muscle Weakness
Phase 4TerminatedVA Office of Research and Development12016-06-012024-05-07
Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty
injection of 1% lidocaine, 2mL for facial nerve block - Facial Paresis
Phase 4TerminatedUniversity Hospital, Caen102013-04-012016-05-25
Haloperidol vs Conventional Therapy for Gastroparesis
Haloperidol, Conventional Therapy - Gastroparesis
Phase 4TerminatedThe University of Texas Health Science Center, Houston362012-11-012017-08-17
Prucalopride Versus Placebo in Gastroparesis
prucalopride, placebo - Gastroparesis
Phase 4TerminatedUniversitaire Ziekenhuizen KU Leuven602011-11-012024-07-10
Does Oral Baclofen Improve Care and Comfort in Spastic Children in Nursing Homes?
oral baclofen + placebo, placebo + oral baclofen - Cerebral Palsy
Phase 4TerminatedShaare Zedek Medical Center202010-10-012018-12-31
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
Tegaserod - Gastroparesis, Diabetes
Phase 4TerminatedNovartis402007-01-012012-05-04
Enterra Therapy Gastric Stimulation System
Enterra Therapy Gastric Stimulator - Gastroparesis
Phase 4TerminatedColumbia University42004-10-012016-08-02
An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus
Cisapride, Placebo - Gastroparesis, Diabetes Mellitus
Phase 4TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.42003-07-012011-01-31
An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options
Cisapride, Placebo - Gastroparesis
Phase 4TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.202003-05-012011-01-24

Narrower conditions

Gastroparesis (6)  ·  Diabetes Mellitus (2)  ·  Quadriplegia (2)  ·  Cerebral Palsy (1)  ·  Facial Paralysis (1)  ·  Spinal Cord Injuries (1)  ·  Stomach Diseases (1)

Broader conditions

Neurologic Manifestations (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Digestive System Diseases (6)  ·  Gastrointestinal Diseases (6)  ·  Stomach Diseases (5)  ·  Nervous System Diseases (3)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Brain Damage, Chronic (1)  ·  Brain Diseases (1)

Interventions

Cisapride (2)  ·  Albuterol (1)  ·  Baclofen (1)  ·  Haloperidol (1)  ·  Lidocaine (1)  ·  prucalopride (1)  ·  tegaserod (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Columbia University (1)  ·  Novartis (1)  ·  Shaare Zedek Medical Center (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Hospital, Caen (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  Belgium (1)  ·  France (1)  ·  Israel (1)

Top investigators

Carlos J Roldan, MD (1)  ·  Dennis L. Fowler, M.D. (1)  ·  Greg Schilero, MD (1)

Results publications

PMID 28646590